 The second wave concerned medical marijuana in the 1990s and 2000s.Though Virginia passed a law with limited effect in 1979, a more widespread trend began in California in 1996.When the FDA requested Endo Pharmaceuticals on June 8, 2017, to remove "oxymorphone hydrochloride" from the market, it was the first such request in FDA history.